Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis
von Eyben, F.E.; Bauman, G.; von Eyben, R.; Rahbar, K.; Soydal, C.; Haug, A.R.; Virgolini, I.; Kulkarni, H.; Baum, R.; Paganelli, G. Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis. Int. J. Mol. Sci. 2020, 21, 9054. https://doi.org/10.3390/ijms21239054
von Eyben FE, Bauman G, von Eyben R, Rahbar K, Soydal C, Haug AR, Virgolini I, Kulkarni H, Baum R, Paganelli G. Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis. International Journal of Molecular Sciences. 2020; 21(23):9054. https://doi.org/10.3390/ijms21239054
Chicago/Turabian Stylevon Eyben, Finn E.; Bauman, Glenn; von Eyben, Rie; Rahbar, Kambiz; Soydal, Cigdem; Haug, Alexander R.; Virgolini, Irene; Kulkarni, Harshad; Baum, Richard; Paganelli, Giovanni. 2020. "Optimizing PSMA Radioligand Therapy for Patients with Metastatic Castration-Resistant Prostate Cancer. A Systematic Review and Meta-Analysis" Int. J. Mol. Sci. 21, no. 23: 9054. https://doi.org/10.3390/ijms21239054